{
  "ticker": "JNJ",
  "target_date": "2025-05-21",
  "actual_date": "2025-05-21",
  "collected_at": "2025-12-08T11:47:31.982847",
  "price": {
    "open": 149.83,
    "high": 151.04,
    "low": 149.64,
    "close": 149.82005310058594,
    "volume": 7032200,
    "change_1d_pct": -0.31,
    "change_7d_pct": -0.62,
    "change_30d_pct": 2.12
  },
  "technicals": {
    "rsi_14": 47.43,
    "sma_20": 150.31,
    "sma_50": 152.98,
    "macd": -1.222,
    "macd_signal": -1.331,
    "macd_histogram": 0.109,
    "bb_upper": 155.77,
    "bb_lower": 144.84,
    "price_vs_sma20_pct": -0.32,
    "price_vs_sma50_pct": -2.07,
    "volume_ratio": 0.88
  },
  "fundamentals": {
    "market_cap": 489159196672,
    "pe_ratio": 19.59749,
    "forward_pe": 19.153772,
    "price_to_book": 6.1623216,
    "price_to_sales": 5.3083506,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.3,
    "pct_from_52w_low": 44.32
  },
  "macro": {
    "spy": {
      "price": 579.54,
      "change_1d_pct": -1.69,
      "change_7d_pct": -0.68
    },
    "vix": {
      "level": 20.87,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.6
    },
    "dollar_index": {
      "level": 99.56
    },
    "gold": {
      "price": 3309.3
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Tracking Jeremy Grantham's GMO Capital Portfolio - Q1 2025 Update",
      "source": "SeekingAlpha",
      "datetime": 1747865679,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=e27504393d6270f71f4779aed94b422dee3a3fcabc889d6582ddb2468c20c3d3"
    },
    {
      "headline": "The FDA Takes a Trial-Lawyer Turn",
      "source": "DowJones",
      "datetime": 1747849260,
      "summary": "The FDA Takes a Trial-Lawyer Turn",
      "url": "https://finnhub.io/api/news?id=982aa4f4432189580bd5c9f9aa05593ee03b460e980f5d00c7dc0e81dc79fea4"
    },
    {
      "headline": "Johnson & Johnson (NYSE:JNJ) FDA Panel Supports DARZALEX FASPRO\u00ae? for High-Risk Multiple Myeloma",
      "source": "Yahoo",
      "datetime": 1747848792,
      "summary": "Johnson & Johnson (NYSE:JNJ) recently garnered attention when the FDA's Oncologic Drugs Advisory Committee voted favorably on the use of DARZALEX FASPRO\u00ae for high-risk smoldering multiple myeloma. This announcement comes amid a broad market environment where the S&P 500 has faced slight declines. Th",
      "url": "https://finnhub.io/api/news?id=acb25ab16e4c49f1fbfd8a771cddc95a5a1ce3b99570292c0500e9f9ee0b6fd1"
    },
    {
      "headline": "Wasatch Global Value Fund Q1 2025 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1747846020,
      "summary": "Wasatch Global Value Fund\u00e2\u0080\u0094Investor Class returned 11.65% in the first quarter of 2024, outperforming the MSCI AC World Value Index. Read more here.",
      "url": "https://finnhub.io/api/news?id=358ba00e56c1f00d27aca22b08d4c6dc9d2d2a95e97a1b095be329ad41f9458b"
    },
    {
      "headline": "Johnson & Johnson to Participate in the Bernstein\u2019s 41st Annual Strategic Decisions Conference",
      "source": "Finnhub",
      "datetime": 1747845663,
      "summary": "Johnson & Johnson will present at the Bernstein\u2019s 41st Annual Strategic Decisions Conference on Wednesday, May 28th, 2025. Management will participate in a Fireside Chat at 9:00 a.m. Eastern...",
      "url": "https://finnhub.io/api/news?id=159a92bae0e1ec36d2a2283baba825611813a8f84bd56e577c92054293495625"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "13F-HR",
      "date": "2025-05-07",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000238/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-05-05",
      "description": "xslF345X05/wk-form4_1746479407.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000143/xslF345X05/wk-form4_1746479407.xml"
    },
    {
      "form": "8-K",
      "date": "2025-04-30",
      "description": "jnj-20250424.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000141/jnj-20250424.htm"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877468.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000138/xslF345X05/wk-form4_1745877468.xml"
    },
    {
      "form": "4",
      "date": "2025-04-28",
      "description": "xslF345X05/wk-form4_1745877247.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000135/xslF345X05/wk-form4_1745877247.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}